Clinical trials design and treatment tailoring: General principles applied to breast cancer research
- 1 August 2006
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 59 (2), 98-105
- https://doi.org/10.1016/j.critrevonc.2005.11.003
Abstract
Nowadays tailored therapy tends to replace standard cancer treatment approaches. Tailoring treatment is possible thanks to clinical trials results that identified subgroups of patients benefiting most from some treatments. Treatment can be tailored on the basis of specific clinical characteristics of the population or on the basis of predictive or prognostic markers. Finally treatment can be tailored for specific molecular targets. This evolution in cancer treatment has triggered the development of innovative trial designs to validate these new hypotheses. The real challenge of the next coming years resides in recruiting large number of patients from specific subgroups to validate tailored therapies.Keywords
This publication has 38 references indexed in Scilit:
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Monoclonal antibodies as therapeutic agents for cancerThe Lancet Oncology, 2004
- Translating Cancer Genomics into Clinical OncologyNew England Journal of Medicine, 2004
- The Phase III Trial in the Era of Targeted Therapy: Unraveling the “Go or No Go” DecisionJournal of Clinical Oncology, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- The Breast International Group: a new spirit of collaboration in breast cancer research for the new millenniumEuropean Journal Of Cancer, 2000
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998